Dr. Elisa Crisci: Next-Gen Vaccine Strategies | Ep. 151
Episode S2 ยท Ep 151 13 min

Dr. Elisa Crisci: Next-Gen Vaccine Strategies | Ep. 151

In this special rerun episode of The Swine Health Blackbelt Podcast, we revisit our conversation with Dr. Elisa Crisci, from North Carolina State University, who joins us to discuss groundbreaking approaches in the fight against porcine reproductive and respiratory syndrome virus (PRRSv). Dr. Crisci shares insights into the "Predict and Protect" project, aiming to enhance disease forecasting and vaccine efficacy prediction using interdisciplinary methods and technologies. Tune in now on all major platforms! "Our interdisciplinary project combines epidemiological modeling and in vitro vaccine testing to predict PRRS outbreaks and recommend targeted strategies." ๐— ๐—ฒ๐—ฒ๐˜ ๐˜๐—ต๐—ฒ ๐—ด๐˜‚๐—ฒ๐˜€๐˜: Dr. Elisa Crisci https://www.linkedin.com/in/elisa-crisci-83181a20/ , Assistant Professor of Virology at North Carolina State University, holds a Ph.D. in Animal Medicine and Health from Universitat Autรฒnoma de Barcelona and a DVM from the University of Bologna. With extensive expertise in pig immunology and virology, she leads groundbreaking research on PRRS management, combining predictive vaccine systems and epidemiological modeling. What you will learn: (00:00) Highlight (00:31) Introduction (01:38) PRRS virus overview (02:39) Predict and protect model (03:45) Vaccine insights (05:14) Challenges in vaccine updates (07:47) Diagnostic tools in focus (11:34) Closing thoughts The Swine Health Blackbelt Podcast is trusted and supported by innovative companies like: * Boehringer Ingelheim (https://www.boehringer-ingelheim.com/) - Farm Health Guardian (http://www.farmhealthguardian.com/) ๐—Ÿ๐—ถ๐˜€๐˜๐—ฒ๐—ป ๐—ผ๐—ป ๐—”๐—ฝ๐—ฝ๐—น๐—ฒ ๐—ฃ๐—ผ๐—ฑ๐—ฐ๐—ฎ๐˜€๐˜๐˜€, ๐—ฆ๐—ฝ๐—ผ๐˜๐—ถ๐—ณ๐˜† ๐—ผ๐—ฟ ๐—ฎ๐—ป๐˜† ๐—บ๐—ฎ๐—ท๐—ผ๐—ฟ ๐—ฝ๐—น๐—ฎ๐˜๐—ณ๐—ผ๐—ฟ๐—บ. Website: https://swinehealthblackbelt.com Instagram: https://www.instagram.com/swinecampus/ LinkedIn: https://www.linkedin.com/company/80692493

Community discussion